Merck Serono

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2025	2	Value not published	2
2024	2	Value not published	2
2023	2	Value not published	2
2022	1	Value not published	1
2018	4	Value not published	4
2017	1	Value not published	1

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierMerck Serono

Source records

Published awards

18 records linked to this supplier.

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender
Buyer: NHS England
End date in notice
30 Apr 2029
Value shown in notice
£1,241,520,444Whole award value; not assigned to one supplier
Official source
Open the official Contracts Finder notice for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
View record references
Source
Contracts Finder
Award or lot reference
ocds-b5fd17-1063d704-a8da-4ec0-b11c-5b9fec849d60 / ocds-b5fd17-1063d704-a8da-4ec0-b11c-5b9fec849d60-1
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
Buyer: NHS England

Merck Serono

Published records by year

Buyer relationships by value counted

Published awards

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NHS South of England Branded Medicines - Tranche A - September 2023

NHS London Branded Medicines - Tranche B - September 2023

NHS Framework for the North of England, Branded Medicine

NHS Framework Agreement for Proprietary Pharmaceuticals - South of England (Tranche A)

NHS England Framework Agreement: South of England (Tranche B)

NHS England Framework Agreement - London - Tranche A

NHS England Framework Agreement: Midlands and East (Tranche A)

NHS Framework Agreement - North of England - Tranche B

Medicinal Products - Direct to Trust

Medicinal Products - with Pharma Funded Homecare Services

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025